Literature DB >> 20460402

Microenvironmental regulation of chemokine (C-X-C-motif) receptor 4 in ovarian carcinoma.

Maria V Barbolina1, Mijung Kim, Yueying Liu, Jaclyn Shepard, Abdelhak Belmadani, Richard J Miller, Lonnie D Shea, M Sharon Stack.   

Abstract

The majority of women diagnosed with epithelial ovarian carcinoma (EOC) succumb due to complications of metastatic disease, suggesting that antimetastatic therapies may improve patient survival. EOC metastasis involves intraperitoneal shedding of cells from the primary tumor, followed by adhesion and localized penetration of the submesothelial matrix to anchor metastatic implants. Accumulation of malignant ascites is also common. Thus, a unique microenvironmental niche is established, which includes malignant cells and a plethora of soluble factors secreted by-or in response to-tumor cells. As cells penetrating the submesothelial surface encounter an interstitial collagen-rich extracellular matrix, we have used three-dimensional type I collagen gels to model early events resulting from intraperitoneal anchoring. In this study, we show a novel pathway of CXCR4 upregulation through beta1 integrin - and NFkappaB-dependent signaling pathways in response to three-dimensional type I collagen. We also show the involvement of CXCR4-SDF1 axis in collagen invasion and proliferation, relevant to the metastatic EOC. Our data show that CXCR4 expression in human EOCs, as well as SDF1 presence in the ascites, is correlated with disease progression and metastasis. These data emphasize the importance of the CXCR4-SDF1 axis in EOC metastasis and suggest that this mechanism should be accounted for when targeting EOC metastasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20460402      PMCID: PMC2883461          DOI: 10.1158/1541-7786.MCR-09-0463

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  52 in total

Review 1.  Stem cell migration: a quintessential stepping stone to successful therapy.

Authors:  Corinna Weidt; Bernd Niggemann; Benjamin Kasenda; Theodore L Drell; Kurt S Zänker; Thomas Dittmar
Journal:  Curr Stem Cell Res Ther       Date:  2007-01       Impact factor: 3.828

Review 2.  Cancer of the ovary.

Authors:  S A Cannistra
Journal:  N Engl J Med       Date:  1993-11-18       Impact factor: 91.245

3.  The chemokine receptor CXCR4 and the metalloproteinase MT1-MMP are mutually required during melanoma metastasis to lungs.

Authors:  Rubén A Bartolomé; Sergio Ferreiro; María E Miquilena-Colina; Lorena Martínez-Prats; María L Soto-Montenegro; David García-Bernal; Juan J Vaquero; Reuven Agami; Rafael Delgado; Manuel Desco; Paloma Sánchez-Mateos; Joaquin Teixidó
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

4.  Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion.

Authors:  Maria V Barbolina; Brian P Adley; David L Kelly; Jaclyn Shepard; Angela J Fought; Denise Scholtens; Peter Penzes; Lonnie D Shea; M Sharon Stack
Journal:  Int J Cancer       Date:  2009-08-15       Impact factor: 7.396

5.  Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma.

Authors:  Maria V Barbolina; Brian P Adley; David L Kelly; Angela J Fought; Denise M Scholtens; Lonnie D Shea; M Sharon Stack
Journal:  Lab Invest       Date:  2008-03-24       Impact factor: 5.662

6.  Epidermal growth factor receptor regulates MT1-MMP and MMP-2 synthesis in SiHa cells via both PI3-K/AKT and MAPK/ERK pathways.

Authors:  Zongfeng Zhang; Tiefang Song; Yinglan Jin; Jiaqi Pan; Liying Zhang; Lingdi Wang; Peiling Li
Journal:  Int J Gynecol Cancer       Date:  2009-08       Impact factor: 3.437

7.  Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis.

Authors:  Mitsuko Furuya; Takahito Suyama; Hirokazu Usui; Yoshitoshi Kasuya; Mariko Nishiyama; Naotake Tanaka; Isamu Ishiwata; Yuichiro Nagai; Makio Shozu; Sadao Kimura
Journal:  Hum Pathol       Date:  2007-08-17       Impact factor: 3.466

8.  Stromal cell-derived factor-1 enhances motility and integrin up-regulation through CXCR4, ERK and NF-kappaB-dependent pathway in human lung cancer cells.

Authors:  Yi-Chia Huang; Yu-Chun Hsiao; Ying-Ju Chen; Ying-Ying Wei; Tzu-Hsu Lai; Chih-Hsin Tang
Journal:  Biochem Pharmacol       Date:  2007-08-25       Impact factor: 5.858

9.  Role of CXCL12 in metastasis of human ovarian cancer.

Authors:  Yu-Ping Jiang; Xiao-Hua Wu; Han-Ying Xing; Xing-Yan DU
Journal:  Chin Med J (Engl)       Date:  2007-07-20       Impact factor: 2.628

10.  Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion.

Authors:  Maria V Barbolina; Brian P Adley; Lonnie D Shea; M Sharon Stack
Journal:  Cancer       Date:  2008-04-01       Impact factor: 6.860

View more
  24 in total

1.  Fractalkine receptor CX(3)CR1 is expressed in epithelial ovarian carcinoma cells and required for motility and adhesion to peritoneal mesothelial cells.

Authors:  Mijung Kim; Lisa Rooper; Jia Xie; Andre A Kajdacsy-Balla; Maria V Barbolina
Journal:  Mol Cancer Res       Date:  2011-11-07       Impact factor: 5.852

Review 2.  The complexity of HIV persistence and pathogenesis in the lung under antiretroviral therapy: challenges beyond AIDS.

Authors:  Sharilyn Almodovar
Journal:  Viral Immunol       Date:  2014-05-05       Impact factor: 2.257

3.  Noninvasive imaging reveals inhibition of ovarian cancer by targeting CXCL12-CXCR4.

Authors:  Paramita Ray; Sarah A Lewin; Laura Anne Mihalko; Bradley T Schmidt; Kathryn E Luker; Gary D Luker
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

Review 4.  CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks.

Authors:  F Guo; Y Wang; J Liu; S C Mok; F Xue; W Zhang
Journal:  Oncogene       Date:  2015-05-11       Impact factor: 9.867

Review 5.  Mechanisms and Targets Involved in Dissemination of Ovarian Cancer.

Authors:  Ulrich H Weidle; Fabian Birzele; Gwendlyn Kollmorgen; Rüdiger Rueger
Journal:  Cancer Genomics Proteomics       Date:  2016 11-12       Impact factor: 4.069

Review 6.  Fallopian tube initiation of high grade serous ovarian cancer and ovarian metastasis: Mechanisms and therapeutic implications.

Authors:  Tova M Bergsten; Joanna E Burdette; Matthew Dean
Journal:  Cancer Lett       Date:  2020-02-15       Impact factor: 8.679

7.  SCF promotes dental pulp progenitor migration, neovascularization, and collagen remodeling - potential applications as a homing factor in dental pulp regeneration.

Authors:  Shuang Pan; Smit Dangaria; Gokul Gopinathan; Xiulin Yan; Xuanyu Lu; Antonia Kolokythas; Yumei Niu; Xianghong Luan
Journal:  Stem Cell Rev Rep       Date:  2013-10       Impact factor: 5.739

Review 8.  The intricate role of CXCR4 in cancer.

Authors:  Samit Chatterjee; Babak Behnam Azad; Sridhar Nimmagadda
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

9.  Imaging CXCL12-CXCR4 signaling in ovarian cancer therapy.

Authors:  Emma Salomonnson; Amanda C Stacer; Anna Ehrlich; Kathryn E Luker; Gary D Luker
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

Review 10.  Small molecule inhibitors of CXCR4.

Authors:  Bikash Debnath; Shili Xu; Fedora Grande; Antonio Garofalo; Nouri Neamati
Journal:  Theranostics       Date:  2013-01-15       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.